Current Science

Open Access Open Access  Restricted Access Subscription Access

Emergence and Burden of Antibiotic Drug Resistance:An Endogenous Cycle


Affiliations
1 Disease Modelling Laboratory, Department of Mathematics, School of Natural Science, Shiv Nadar University, Greater Noida 201 314, India
 

Antibiotic drug resistance is a global crisis today. The deleterious impact of this crisis is acting relatively in higher degrees in poor nations compared to developed countries in the world. Low economy and irrational perspective on medical practice are accelerating the development of drug resistance, leading the population in more economically challenged situations. This article discusses current situations, expresses opinions and views on the self-reinforcement process in the emergence and development of drug resistance.
User
Notifications
Font Size

  • Lodato, E. M. and Kaplan, W., Background paper 6.1 antimicrobial resistance. World Health Organization, Geneva, 2013.

  • Lee Ventola, C., Pharm. Therap., 2015, 40(4), 277.

  • WHO, Global antimicrobial resistance surveillance system (GLASS) Report: early implementation 2017–2018, World Health Organization, Geneva, 2018.

  • Pimentel, D. et al., Bioscience, 1998, 48(10), 817–826.

  • O’Neill, J., Antimicrobial resistance: tackling a crisis for the health and wealth of nations 2004; Review on Antimicrobial Resistance, London, UK, 2014.

  • Robinson, T. P. et al., Trans. R. Soc. Trop. Med. Hyg., 2016, 110(7), 377– 380.

  • Levy, S. B. and Marshall, B., Nature Med., 2004, 10(12s), S122.

  • Alividza, V., Mariano, V., Ahmad, R., Charani, E., Rawson, T. M., Holmes, A. H. and Castro-Sánchez, E., Infect. Dis. Poverty, 2018, 7(1), 76.

  • Holmes, A. H. et al., Lancet, 2016, 387(10014), 176–187.

  • Shrestha, P. et al., Antimicrob. Resistance Infect. Control, 2018, 7(1), 98.

  • Laxminarayan, R. et al., Lancet Infect. Dis., 2013, 13(12), 1057–1098.

  • Goossens, H. et al., Lancet, 2005, 365(9459), 579–587.

  • Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H. and Pringle, M., BMC Infect. Dis., 2014, 14(1), 13.

  • Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A. and Laxminarayan, R., Lancet Infect. Dis., 2014, 14(8), 742–750.

  • Klein, E. Y. et al., Proc. Natl. Acad. Sci. USA, 2018, 115(15), E3463–E3470.

  • Nathan, C. and Cars, O., New Engl. J. Med., 2014, 371(19), 1761–1763.

  • French, G. L., Int. J. Antimicrob. Agents, 2010, 36, S3–S7.

  • Read, A. F. and Woods, R. J., Evol., Med. Public Health, 2014, 2014(1), 147.

  • Bennadi, D., J. Basic Clin. Pharm., 2013, 5(1), 19.

  • Mamun, K. Z., Shears, P. and Hart, C. A., Epidemiol. Infect., 1993, 110(3), 447–458.

  • Moshaddeque Hossain, M., Glass, R. I. and Khan, M. R., Int. J. Epidemiol., 1982, 11(4), 402–405.

  • Chang Fwu-Ranq and Trivedi, P. K., Health Econ., 2003, 12(9), 721–739.

  • Istúriz, R. E. and Carbon, C., Infect. Control Hosp. Epidemiol., 2000, 21(6), 394–397.

  • Sawalha, A. F., Res. Soc. Admin. Pharm., 2008, 4(2), 164–172.

  • Manole, M. et al., Rev. Med. Chir. Soc. Med. Nat. laşi, 2017, 121(3), 608–615.

  • Sharma, R. et al., Indian J. Pharmacol., 2005, 37(1), 40.

  • Malik, B. and Bhattacharyya, S., Sci. Rep., 2019, 9(1), 9788.

  • Gould, I. M. and Bal, A. M., Virulence, 2013, 4(2), 185–191.

  • Spellberg, B. and Gilbert, D. N., Clin. Infect. Disease (Suppl. 2), 2014, 59, S71–S75.


Abstract Views: 441

PDF Views: 147




  • Emergence and Burden of Antibiotic Drug Resistance:An Endogenous Cycle

Abstract Views: 441  |  PDF Views: 147

Authors

Bhawna Malik
Disease Modelling Laboratory, Department of Mathematics, School of Natural Science, Shiv Nadar University, Greater Noida 201 314, India
Samit Bhattacharyya
Disease Modelling Laboratory, Department of Mathematics, School of Natural Science, Shiv Nadar University, Greater Noida 201 314, India

Abstract


Antibiotic drug resistance is a global crisis today. The deleterious impact of this crisis is acting relatively in higher degrees in poor nations compared to developed countries in the world. Low economy and irrational perspective on medical practice are accelerating the development of drug resistance, leading the population in more economically challenged situations. This article discusses current situations, expresses opinions and views on the self-reinforcement process in the emergence and development of drug resistance.

References





DOI: https://doi.org/10.18520/cs%2Fv118%2Fi2%2F189-191